Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.59B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 3 |
Microsoft
MSFT
|
+$794M |
| 4 |
Home Depot
HD
|
+$512M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$491M |
| 2 |
Linde
LIN
|
+$373M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$298M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$290M |
| 5 |
Salesforce
CRM
|
+$249M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.37% |
| 2 | Healthcare | 7.45% |
| 3 | Consumer Discretionary | 5.14% |
| 4 | Industrials | 5.1% |
| 5 | Financials | 4.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4476
Sylvamo
SLVM
$1.49B
| $501K | ﹤0.01% |
12,383
-200,539
| -94% | -$8.66M |
|
|
RNAM
4477
DELISTED
Avidity Biosciences
RNAM
| $501K | ﹤0.01% |
+45,140
| New | +$566K |
|
4478
PUT
Icon
ICLR
$12.6B
| $500K | ﹤0.01% |
2,000
-3,000
| -60% | -$637K |
|
4479
Unity Bancorp
UNTY
$591M
| $500K | ﹤0.01% |
21,202
-4,786
| -18% | -$109K |
|
4480
PUT
Vaxcyte
PCVX
$7.81B
| $499K | ﹤0.01% |
+10,000
| New | +$474K |
|
|
HUT
4481
Hut 8
HUT
$12.1B
| $499K | ﹤0.01% |
30,052
-21,236
| -41% | -$218K |
|
4482
TriplePoint Venture Growth BDC
TPVG
$184M
| $499K | ﹤0.01% |
42,361
+25,293
| +148% | +$286K |
|
4483
Vanguard FTSE Developed Markets ETF
VEA
$229B
| $499K | ﹤0.01% |
10,800
-16,740
| -61% | -$770K |
|
4484
CALL
XPeng
XPEV
$12.4B
| $498K | ﹤0.01% |
37,100
+18,900
| +104% | +$186K |
|
4485
James Hardie Industries
JHX
$15.3B
| $498K | ﹤0.01% |
+18,506
| New | +$447K |
|
|
LGF.A
4486
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
| $497K | ﹤0.01% |
56,332
+30,506
| +118% | +$321K |
|
|
DOC
4487
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $497K | ﹤0.01% |
+35,528
| New | +$505K |
|
|
LBC
4488
DELISTED
Luther Burbank Corporation Common Stock
LBC
| $496K | ﹤0.01% |
+55,648
| New | +$504K |
|
|
DCFC
4489
DELISTED
Tritium DCFC Limited Ordinary Shares
DCFC
| $495K | ﹤0.01% |
2,271
-545
| -19% | -$118K |
|
|
IVAC
4490
DELISTED
Intevac Inc
IVAC
| $495K | ﹤0.01% |
131,887
-140,430
| -52% | -$753K |
|
|
WE
4491
DELISTED
WeWork Inc.
WE
| $495K | ﹤0.01% |
58,775
-2,377
| -4% | -$32.9K |
|
4492
CALL
Opendoor
OPEN
$3.64B
| $492K | ﹤0.01% |
126,583
+15,293
| +14% | +$33.2K |
|
|
OMGA
4493
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
| $492K | ﹤0.01% |
87,897
-125,893
| -59% | -$985K |
|
4494
BayCom
BCML
$329M
| $491K | ﹤0.01% |
29,463
-22,410
| -43% | -$370K |
|
4495
CALL
Tandem Diabetes Care
TNDM
$1.34B
| $491K | ﹤0.01% |
+20,000
| New | +$643K |
|
|
4496
PUT
Tandem Diabetes Care
TNDM
$1.34B
| $491K | ﹤0.01% |
+20,000
| New | +$643K |
|
4497
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
$11.5B
| $489K | ﹤0.01% |
15,242
-155,579
| -91% | -$5.02M |
|
4498
CALL
Ball Corp
BALL
$17.3B
| $489K | ﹤0.01% |
+8,400
| New | +$455K |
|
4499
CALL
Manchester United
MANU
$3.97B
| $488K | ﹤0.01% |
20,000
-128,400
| -87% | -$2.66M |
|
|
BGRYW
4500
CALL
DELISTED
Berkshire Grey, Inc. Warrant
BGRYW
| $487K | ﹤0.01% |
1,453,464
+324,703
| +29% | +$106K |
|
Similar funds
Millennium Management's Q2 2023 Portfolio in Review
As of Q2 2023, Millennium Management held 7,181 positions worth $203B, up 16% from $174B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Millennium Management deployed $14B of net new capital in Q2 2023, opening 869 new positions and adding to 2,214 existing holdings. Its largest new stake was ResMed: 632,015 shares worth $138M.
By sector, the portfolio is most concentrated in Technology at 8.4% of assets, up from 8.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Tesla, an estimated $491M trimmed.
- Millennium Management's largest Q2 2023 buy was ResMed: 632,015 shares worth $138M.
- Millennium Management added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $1.59B increase.
- Millennium Management's biggest Q2 2023 reduction was Tesla, cutting an estimated $491M.
- Millennium Management fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $237M.
- Millennium Management's ten largest holdings make up 26% of its $203B portfolio in Q2 2023.
- Millennium Management opened 869 new positions and closed 1,192 in Q2 2023.
- Millennium Management's portfolio value rose 16% quarter-over-quarter to $203B.
Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.